0001752864-23-000002.txt : 20231023 0001752864-23-000002.hdr.sgml : 20231023 20231023130600 ACCESSION NUMBER: 0001752864-23-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231019 FILED AS OF DATE: 20231023 DATE AS OF CHANGE: 20231023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Altchem Ltd CENTRAL INDEX KEY: 0001752864 STATE OF INCORPORATION: G4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38709 FILM NUMBER: 231339521 BUSINESS ADDRESS: STREET 1: KARAISKAKI 6 STREET 2: CITY HOUSE CITY: LIMASSOL STATE: G4 ZIP: 3032 BUSINESS PHONE: 35725555000 MAIL ADDRESS: STREET 1: KARAISKAKI 6 STREET 2: CITY HOUSE CITY: LIMASSOL STATE: G4 ZIP: 3032 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Orbit Co-Invest A-1 LLC CENTRAL INDEX KEY: 0001753129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38709 FILM NUMBER: 231339520 BUSINESS ADDRESS: STREET 1: 895 SAWYER ROAD CITY: MARIETTA STATE: GA ZIP: 30062 BUSINESS PHONE: 7705094500 MAIL ADDRESS: STREET 1: 895 SAWYER ROAD CITY: MARIETTA STATE: GA ZIP: 30062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RVL Pharmaceuticals plc CENTRAL INDEX KEY: 0001739426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 9088091300 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Osmotica Pharmaceuticals plc DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: Osmotica Pharmaceuticals Ltd DATE OF NAME CHANGE: 20180502 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-10-19 1 0001739426 RVL Pharmaceuticals plc RVLP 0001752864 Altchem Ltd CITY HOUSE 6 KARAISKAKIS STREET LIMASSOL G4 3032 CYPRUS 0 0 1 0 0001753129 Orbit Co-Invest A-1 LLC 885 3RD AVENUE 17TH FLOOR NEW YORK NY 10022 0 0 1 0 0 Ordinary Shares 2023-10-19 4 S 0 9363760 0.0461 D 9700000 D Ordinary Shares 2023-10-20 4 S 0 4758899 0.0312 D 4941101 D Ordinary Shares 1182243 I By Self as Sole Manager of Orbit Co-Invest A-1 LLC The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0400 to $0.0580, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0300 to $0.0373, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. /s/MILITSA SYMEOU, Altchem Limited, by Militsa Symeou, its Director 2023-10-23 /s/MILITSA SYMEOU, Orbit Co-Invest A-1 LLC, by Altchem Limited, its sole manager 2023-10-23